Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain
- 1 January 1997
- journal article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 18 (1), 111-120
- https://doi.org/10.1016/s0197-4580(96)00205-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Amyloid β protein disruption of cholinergic and growth factor phosphoslipase C signals could underlie cognitive and neurodegerative aspects of Alzheimer's diseaseNeurobiology of Aging, 1994
- Cholinergic and serotonergic stimulation of phosphoinositide hydrolysis is decreased in Alzheimer's diseaseLife Sciences, 1994
- Effects of Alzheimer's disease-related β amyloid protein fragments on enzymes metabolizing phosphoinositides in brainBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligandsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Agonist‐Induced, GTP‐Dependent Phosphoinositide Hydrolysis in Postmortem Human Brain MembranesJournal of Neurochemistry, 1994
- Coupling of muscarinic receptors to GTP proteins in postmortem human brain — alterations in Alzheimer's diseaseNeuroscience Letters, 1993
- Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in alzheimer's diseaseLife Sciences, 1993
- Brain signal transduction disturbances in neurodegenerative disordersCellular Signalling, 1992
- Alzheimer's DiseaseNew England Journal of Medicine, 1986
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975